Nervgen remyelination drug phase 1
Re: Nervgen remyelination drug phase 1
https://finance.yahoo.com/news/nervgen- ... 01%20Trial
"...Phase 1 program supports plan to start clinical trials in H2 2022 for NervGen's NVG-291 in spinal cord injury, multiple sclerosis and Alzheimer's disease indications
Screening of healthy volunteers has already started for the trial's multiple ascending dose (MAD) portion
In preclinical studies, NVG-291 has been shown to promote repair of nervous system damage...?
"...Phase 1 program supports plan to start clinical trials in H2 2022 for NervGen's NVG-291 in spinal cord injury, multiple sclerosis and Alzheimer's disease indications
Screening of healthy volunteers has already started for the trial's multiple ascending dose (MAD) portion
In preclinical studies, NVG-291 has been shown to promote repair of nervous system damage...?
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 165 Views
-
Last post by DIM
-
- 10 Replies
- 2800 Views
-
Last post by NHE
-
- 0 Replies
- 1337 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1293 Views
-
Last post by DIM
-
- 0 Replies
- 1105 Views
-
Last post by frodo
-
- 0 Replies
- 1302 Views
-
Last post by NHE
-
- 0 Replies
- 1156 Views
-
Last post by frodo
-
- 0 Replies
- 1517 Views
-
Last post by DIM
-
- 0 Replies
- 2031 Views
-
Last post by DIM